{
    "title": "Alnylam gives up on expanded use of heart-disease drug in US after FDA declines approval",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12610505/US-FDA-declines-approval-expanded-use-Alnylams-heart-disease-drug.html",
    "date": "2023-10-09",
    "keywords": [
        "drug",
        "attr",
        "cardiomyopathy",
        "use",
        "heart",
        "company",
        "regulator",
        "patisiran",
        "amyloidosis",
        "damage",
        "adult",
        "decision",
        "analyst",
        "fda",
        "vutrisiran",
        "oct",
        "monday",
        "disease",
        "food",
        "administration",
        "medication",
        "recommendation",
        "trading",
        "response",
        "letter",
        "condition",
        "muscle",
        "transthyretin",
        "onpattro",
        "availability",
        "alnylam",
        "rejection",
        "instance",
        "fdas",
        "panel",
        "month",
        "meaningfulness",
        "rbc",
        "capital",
        "luca",
        "issi",
        "note",
        "safety",
        "quality",
        "study",
        "conduct",
        "brand",
        "candidate",
        "injection",
        "latestage",
        "william",
        "blair",
        "treatment",
        "reporting",
        "mariam",
        "sunny",
        "bengaluru",
        "editing",
        "pooja",
        "desai"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}